Background In the CLARITY AD study, lecanemab was shown to reduce markers of amyloid and slow cognitive decline at 18 months in early Alzheimer’s disease (AD). Here, we report the initial findings ...

Correspondence to: Dr Uta Schick Clinic of Neurological Surgery, Wedau Kliniken, Zu den Rehwiesen 9, 47055 Duisburg, Germany; Uta_Schickweb.de Objective: To present a large series of surgically ...

1 Department of Neurology, University of Iowa, Iowa City, Iowa, USA 2 Department of Neurology, University of Minnesota, Minneapolis, Minnesota, USA Correspondence to: Dr Praful Kelkar, Department of ...

Department of Neurosurgery, University of Mississippi Medical Center, Jackson, Mississippi, USA Dr J Zhang, Department of Neurosurgery, University of Mississippi Medical Center, 2500 N State Street, ...

Correspondence to Dr Ya Miao, Department of Geriatrics, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China; nning-my{at}163.com; Prof Qihao Guo, Department of Geriatrics ...

Department of Medicine, University Hospital, Nottingham, UK. Data from 357 conscious stroke patients taking part in an acute intervention trial and assessed within 48 hours of the onset of symptoms, ...

Background For more than 15 years, deep brain stimulation (DBS) has served as a last-resort treatment for severe treatment-resistant obsessive-compulsive disorder (OCD). Methods From 2010 to 2016, 20 ...

Detailed neurological examinations, EEG and CT scans of the head were performed on 10 professional boxers aged 20 to 31 years shortly after being knocked-out. Intracerebral and subdural haematomas ...

Correspondence to Dr Casey H Halpern, Department of Neurosurgery, Stanford University, Stanford, CA 94305-5327, USA; chalpern{at}stanford.edu Background The safety and efficacy of neuroablation (ABL) ...

Dr Sergio Paradiso, University of Iowa College of Medicine Psychiatry Research, MEB, Iowa City, IA 52241, USA. Telephone 001 319 353 4446; fax 001 319 353 3003; email sergio-paradiso{at}uiowa.edu ...

Background Understanding the sequential progression of cognitive impairments in Parkinson’s disease (PD) is crucial for elucidating neuropathological underpinnings, refining the assessment of ...

1 Department of Neurosciences and Institute of Molecular Medicine, Faculty of Medicine, University of Lisbon, Lisbon, Portugal 2 Department of Clinical Neuroscience, Barts and the London School of ...